Anti-Human Synuclein-beta antiserum # 1
General Information
The synuclein exists in 3 isoform -syn (chrm 4q21), a 140aa protein, implicated in pathogenesis of PD and related neurodegenerative disorders, it is mainly expressed in brain specifically in neuronal cell bodies and synapses. The 134 aa -syn (chrm 5q35)
SugApplications
Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the
SugSecAntibodies
http://4adi.com/comm
SpeciesReactivity
Human
SugNegativeControl
Non-immune Rabbit IgG Cat# 20009-1
Form
Antiserum Unpurified
SugPositiveControl
Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid
Antigen
15-aa peptide of Human beta SYN1; Designated (SYN13-P or control peptide). conjugated to KLH, epitope location ~ C-terminus
SpCrossreactivity
The SYN13 peptide sequence is 100% identical in rat beta-synuclein (137 aa) bovine PNP14 (134 aa) and 86% in chicken. It has no appreciable homology with synuclein-alpha or other proteins
For research use only, not for diagnostic or therapeutic use.
| Alpha Diagnostic International, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | SYN13-S |
| Product Name | Anti-Human Synuclein-beta antiserum # 1 |
